Skip to main content

Mucus Relief

NDC 50804-371 · Good Sense

Generic nameGuaifenesin 400mg
Dosage formTABLET
RouteORAL
Active ingredient(s)GUAIFENESIN
Strength400 mg/1
Pharmacologic classDecreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]
Marketing categoryOTC MONOGRAPH DRUG

Packages

50804-371-30 — 1 BOTTLE in 1 CARTON (50804-371-30) / 30 TABLET in 1 BOTTLE

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

50580-403 — Acetaminophen, dextromethorphan hydrobromide, guaifenesin, and phenylephrine hydrochloride, 50580-447 — acetaminophen, guaifenesin, and phenylephrine hydrochloride, 50580-450 — Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, and Phenylephrine Hydrochloride, 50580-507 — Acetaminophen, Guaifenesin, and Phenylephrine Hydrochloride, 50580-511 — Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, and Phenylephrine hydrochloride, 50580-566 — Acetaminophen, Guaifenesin, and Phenylephrine Hydrochloride, 50580-584 — Acetaminophen, Guaifenesin, 50804-173 — ACETAMINOPHEN, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE, 50804-256 — Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl, 50804-274 — ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE, 50804-432 — Mucus Relief DM, 50804-503 — Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl, 50804-672 — ACETAMINOPHEN, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE, 50804-805 — ACETAMINOPHEN, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE, 50844-004 — Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl, 50844-572 — Acetaminophen, Guaifenesin, Phenylephrine HCl, 50844-633 — Dextromethorphan HBr and Guaifenesin, 50844-640 — Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl, 50991-212 — Guaifenesin and Pseudoephedrine HCl, 50991-214 — Dextromethorphan HBr, Guaifenesin and Pseudoephedrine HCl, +1437 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels